157 related articles for article (PubMed ID: 37186071)
1. Retinoic acid promotes differentiation of WiT49- but not of CCG99-11 Wilms tumour cells.
Jansson C; Mengelbier LH
Cancer Rep (Hoboken); 2023 Jun; 6(6):e1819. PubMed ID: 37186071
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro.
Wegert J; Bausenwein S; Kneitz S; Roth S; Graf N; Geissinger E; Gessler M
Mol Cancer; 2011 Nov; 10():136. PubMed ID: 22067876
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic Wilms tumor xenografts derived from cell lines reflect limited aspects of tumor morphology and clinical characteristics.
Mengelbier LH; Bexell D; Sehic D; Ciornei CD; Gisselsson D
Pediatr Blood Cancer; 2014 Nov; 61(11):1949-54. PubMed ID: 25044705
[TBL] [Abstract][Full Text] [Related]
4. Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy - Case report.
Friesenbichler W; Krizmanich W; Lakatos K; Attarbaschi A; Dworzak M; Amann G; Furtwängler R; Graf N; Kager L
Pediatr Hematol Oncol; 2018 Apr; 35(3):218-224. PubMed ID: 30260265
[TBL] [Abstract][Full Text] [Related]
5. All-trans-retinoic acid-induced growth suppression of blastemal Wilms' tumor.
Vincent TS; Re GG; Hazen-Martin DJ; Tarnowski BI; Willingham MC; Garvin AJ
Pediatr Pathol Lab Med; 1996; 16(5):777-89. PubMed ID: 9025876
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.
Zirn B; Samans B; Spangenberg C; Graf N; Eilers M; Gessler M
Oncogene; 2005 Aug; 24(33):5246-51. PubMed ID: 15897880
[TBL] [Abstract][Full Text] [Related]
7. A multi-Gaussian model for apparent diffusion coefficient histogram analysis of Wilms' tumour subtype and response to chemotherapy.
Hales PW; Olsen ØE; Sebire NJ; Pritchard-Jones K; Clark CA
NMR Biomed; 2015 Aug; 28(8):948-57. PubMed ID: 26058670
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyomatous differentiation in primary Wilms tumor and hepatic metastases after chemotherapy and all-trans-retinoic acid in combination with interferon-α.
Chao YH; Wu HP; Chiang IP; Peng CT; Yang YL; Wu KH
Pediatr Blood Cancer; 2011 Oct; 57(4):698-9. PubMed ID: 21648057
[No Abstract] [Full Text] [Related]
9. Spectrum of pediatric kidney tumours with special references to WT1 immunostain at a tertiary care hospital.
Das C; Mukhopadhyay M; Maity N; Parvin T; Mukhopadhyay B; Mukhopadhyay B
J Cancer Res Ther; 2022; 18(1):209-213. PubMed ID: 35381785
[TBL] [Abstract][Full Text] [Related]
10. Post therapy Wilms tumour or ectopic immature renal tissue: A pathologist's diagnostic dilemma.
Guntiboina VA; Islam N; Banerjee S; Chatterjee U
Indian J Pathol Microbiol; 2019; 62(2):266-269. PubMed ID: 30971552
[TBL] [Abstract][Full Text] [Related]
11. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
15. Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.
Li MH; Sanchez T; Pappalardo A; Lynch KR; Hla T; Ferrer F
Mol Cancer Res; 2008 Oct; 6(10):1649-56. PubMed ID: 18922980
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a WiT49 cell line derived orthotopic model of Wilms tumor.
Li MH; Yamase H; Ferrer F
Pediatr Blood Cancer; 2010 Feb; 54(2):316-8. PubMed ID: 19824073
[TBL] [Abstract][Full Text] [Related]
17. Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?
Borgstein E; Kamiza S; Vujanic G; Pidini D; Bailey S; Tomoka T; Banda K; Kaspers G; Molyneux E; Israels T
Pediatr Blood Cancer; 2014 Dec; 61(12):2180-4. PubMed ID: 25213396
[TBL] [Abstract][Full Text] [Related]
18. Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.
Percicote AP; Mardegan GL; Gugelmim ES; Ioshii SO; Kuczynski AP; Nagashima S; de Noronha L
Diagn Pathol; 2018 Jan; 13(1):9. PubMed ID: 29378601
[TBL] [Abstract][Full Text] [Related]
19. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy in Wilms' tumour.
Thomas PR
Ann Acad Med Singap; 1996 May; 25(3):425-8. PubMed ID: 8876911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
